Skip to content
ChickenStockChickenStock
ResearchFilings

AI English summary of an SEC filing — figures as filed

Zimmer Biomet logoZimmer Biomet ZBH

The company said Chairman of the Board Christopher Begley is not eligible for nomination by the Board for election as a director at the 2025 Annual Meeting under the mandatory director retirement policy, and will retire from the Board when his current term expires at that meeting.

8-KDeparture or Appointment of Directors or Certain OfficersFiled Period of report Summary published (UTC)

Key points

AI summary
  1. The company said Chairman of the Board Christopher Begley is not eligible for nomination by the Board for election as a director at the 2025 Annual Meeting under the mandatory director retirement policy, and will retire from the Board when his current term expires at that meeting.

  2. The company said the Board, upon the recommendation of the Corporate Governance Committee, appointed Ivan Tornos, its President, Chief Executive Officer and a director, as Chairman of the Board, effective on May 29, 2025.

  3. The company said it appointed Michael Farrell as Lead Independent Director effective upon Mr. Tornos' commencement of service as Chairman. Farrell has been a Board member since 2014 and serves as Chairman of the Compensation and Management Development Committee.

  4. The company said the Board took action to reduce its size to 10 members (ten members) effective upon the expiration of Mr. Begley's term as director.

Summary

AI-written

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

Christopher Begley to Retire from Board

The company said Chairman of the Board Christopher Begley is not eligible for nomination by the Board for election as a director at the 2025 Annual Meeting under the mandatory director retirement policy, and will retire from the Board when his current term expires at that meeting.

Source · Based on the filing body and exhibits

Ivan Tornos Appointed Chairman of the Board

The company said the Board, upon the recommendation of the Corporate Governance Committee, appointed Ivan Tornos, its President, Chief Executive Officer and a director, as Chairman of the Board, effective on May 29, 2025.

Source · Based on the filing body and exhibits

Michael Farrell Appointed Lead Independent Director

The company said it appointed Michael Farrell as Lead Independent Director effective upon Mr. Tornos' commencement of service as Chairman. Farrell has been a Board member since 2014 and serves as Chairman of the Compensation and Management Development Committee.

Source · Based on the filing body and exhibits

Board Size Reduced to 10 Members

The company said the Board took action to reduce its size to 10 members (ten members) effective upon the expiration of Mr. Begley's term as director.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

Source: SEC EDGAR (U.S. Securities and Exchange Commission). Item captions are the SEC's. The summary is for reference only and is not investment advice.